🔎 Trials Near Me

Home › Uveal Melanoma › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Uveal Melanoma sa Philadelphia, PA

Isang pag-aaral para sa Uveal Melanoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

Nagre-recruitPhase 3
  • Wills Eye Hospital at Thomas Jefferson University, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07804186

Tebentafusp-tebn With LDT in Metastatic UM

Nagre-recruitPhase 1/2
  • Thomas Jefferson University, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT06626516

Neoadjuvant Tebentafusp for Uveal Melanoma

Nagre-recruitPhase 2
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT06414590

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

Nagre-recruitPhase 1/2
  • Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 8, 2026 · NCT03947385

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Nagre-recruitPhase 1/2
  • University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
  • Thomas Jefferson University, Honickman Center, Philadelphia
  • Fox Chase Cancer Center, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Nagre-recruitPhase 3
  • Jefferson Health Honickman Center, Philadelphia
Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Nagre-recruitPhase 2/3
  • Thomas Jefferson University, Philadelphia
Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Pag-aaral para sa Uveal Melanoma sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.